| Previous Close | 3.62 |
| Open | 3.65 |
| Day High | 3.68 |
| Day Low | 3.56 |
| 52-Week High | 8.4 |
| 52-Week Low | 3.56 |
| Volume | 5.69M |
| Average Volume | 4.3M |
| Market Cap | 884.36M |
| PE | -16.73 |
| EPS | -0.21 |
| Moving Average 50 Days | 4.52 |
| Moving Average 200 Days | 5.83 |
| Change | -0.04 |
Ardelyx Announces Publication of a Review Article Demonstrating Rapid and Meaningful Symptom Relief with Tenapanor in IBS-C
GlobeNewswire Inc.
Mar 09, 2026 8:05 PM GMT
Post hoc analysis supports a reduction of time to first bowel movement and a consistent improvement in abdominal symptoms, including pain, discomfort, and bloating, during 12 weeks of treatmentWALTHAM, Mass., March 09, 2026 (GLOBE NEWSWIRE) -- Arde
Ardelyx and the LPGA Announce Multi-Year Partnership to Break Stigma Around Digestive Health Issues Impacting Millions
GlobeNewswire Inc.
Feb 24, 2026 1:00 PM GMT
First-of-its-kind partnership designed to educate and mobilize patients to imagine a healthier tomorrowDAYTONA BEACH, Fla. and WALTHAM, Mass., Feb. 24, 2026 (GLOBE NEWSWIRE) -- The Ladies Professional Golf Association (LPGA) and Ardelyx (Nasdaq: AR
Ardelyx to Report Full Year and Fourth Quarter 2025 Financial Results on February 19, 2026
GlobeNewswire Inc.
Feb 05, 2026 1:00 PM GMT
Conference call scheduled for 4:30 p.m. Eastern TimeWALTHAM, Mass., Feb. 05, 2026 (GLOBE NEWSWIRE) -- Ardelyx, Inc. (Nasdaq: ARDX), a biopharmaceutical company founded with a mission to discover, develop and commercialize innovative, first-in-class